Osa Surgery denied as experimental or investigational by Humana?

Humana's specific coverage criteria for osa surgery are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied OSA Surgery as Experimental

Humana may classify a specific OSA surgical procedure as experimental or investigational if the procedure is newer, involves an implantable device (such as a hypoglossal nerve stimulator), or if the evidence base has not yet reached the threshold defined in Humana's clinical policy. This type of denial is more common for certain surgical approaches than for established upper-airway procedures, and the specific procedure requested matters significantly. An experimental denial for a well-established procedure may reflect a policy lag or a coding/documentation issue rather than a genuine clinical disagreement.

## Why This Denial Is Appealable

Experimental denials are among the most frequently overturned categories in independent external review, particularly when the procedure in question has received FDA clearance or approval (for device-based surgical therapies) and when professional society guidelines endorse the procedure for appropriately selected patients. Humana's experimental classification is a medical judgment, not a contractual absolute, and it must be evaluated against current clinical evidence. Under ACA §2719, experimental/investigational denials are explicitly subject to independent external review by a clinically qualified specialist.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA §2719): File within 180 days of the denial. Humana must respond within 30 days for pre-service denials. Your appeal should directly engage the specific language in Humana's clinical policy that classifies the procedure as experimental.
• External review: After exhausting internal appeals, request independent external review. For experimental/investigational denials specifically, the external reviewer must be a clinical specialist in the relevant field. The window is generally 4 months from the final internal adverse determination. The external reviewer's decision is binding on Humana.
• Expedited review: If OSA severity creates an urgent health risk (documented cardiovascular complications, severe nocturnal hypoxemia, occupational safety risk), request expedited internal and external review simultaneously.
• State insurance department: If Humana misses its decision deadlines or fails to provide a clinically reasoned denial, file a complaint with your state insurance commissioner.

## Documentation to Gather

1. Procedure identification — confirm the exact procedure name, CPT code, and where applicable the specific device (including FDA clearance/approval status), so the appeal addresses the correct clinical policy. 2. Diagnosis confirmation — polysomnography or home sleep study confirming OSA diagnosis, severity, and relevant anatomical or physiological findings supporting the surgical indication. 3. Prior-treatment failure documentation — dated records of non-surgical therapies tried (CPAP, oral appliance, positional therapy), with adherence data, outcomes, and documented reasons for failure or intolerance. 4. Surgeon's medical-necessity letter — should identify the specific Humana policy language classifying the procedure as experimental, provide the published clinical evidence supporting the procedure for your patient profile, and reference the applicable sleep medicine or surgical society guideline organization's endorsement of the procedure. 5. FDA clearance or approval documentation — for device-based procedures, include reference to the relevant FDA 510(k) clearance or PMA approval. 6. Guideline support — cite the relevant professional society (e.g., American Academy of Sleep Medicine, American Academy of Otolaryngology) generically to establish that the procedure is considered standard of care for appropriately selected patients.

## Criteria-Mapping Structure

Obtain the specific Humana clinical policy bulletin cited in your denial letter. Copy each criterion used to classify the procedure as experimental into a table. For each criterion, your surgeon's letter should provide the counterevidence: FDA status, peer-reviewed literature support (by journal and year, without fabricated statistics), and professional society endorsement. This point-by-point rebuttal is the format most likely to succeed at both internal appeal and external review.